Pediatric Oncology

Top Story

AACR: Advances in cancer research, medical funding allow for ‘phenomenal’ progress

AACR: Advances in cancer research, medical funding allow for ‘phenomenal’ progress
October 17, 2017

Oncology leaders who participated in an American Association for Cancer Research webinar this afternoon highlighted several advances in cancer research and emphasized the importance of robust medical research funding.

Webinar participants also provided updates on the seventh annual AACR Cancer Progress Report, released last month. The report — titled “Harnessing Research Discoveries to Save Lives” — provided a snapshot of cancer progress this year, and also offered recommendations to increase public understanding and advocate for increased federal funding.

NIH collaboration aims to identify, validate immunotherapy biomarkers

October 13, 2017
NIH launched the Partnership for Accelerating Cancer Therapies, a 5-year public-private research collaboration. The $215 million effort is part of the national cancer…
Meeting News

Ethanol lock therapy ineffective at preventing, treating CLABSIs

October 9, 2017
SAN DIEGO — No benefits have been observed from the use of ethanol lock therapy as a treatment or prophylaxis for central line-associated bloodstream infections in…
In the Journals PlusPerspective

Crizotinib effectively targets ALK pathway in pediatric cancers

October 9, 2017
Crizotinib induced robust and sustained clinical responses in children with relapsed anaplastic large cell lymphoma and metastatic or unresectable inflammatory…
More Headlines »
CME

Diagnostic and Therapeutic Challenges in Von Willebrand Disease

This activity is supported by an educational grant from Shire.

With the significant variability in the subtypes and clinical manifestations of von Willebrand disease (VWD), diagnosis…
More »
Video

Baseball Hall of Famer Mike Schmidt ‘paying it forward’ through campaign to support patients with cancer

September 21, 2017
More »
Resource Centers
European Society for Medical Oncology Congress

European Society for Medical Oncology Congress

CME

Multiple Myeloma Patient Management: Embracing New Advancements, Overcoming New Challenges

Support for this activity has been provided through educational grants from Amgen; Celgene Corporation; Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC; and Takeda Oncology.

The multiple myeloma clinical landscape has evolved significantly, with not only 10 new drugs but also new staging…
More »
Advertisement
Advertisement